Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s biggest contract chipmaker, yesterday said it would again budget more than US$40 billion for capital expenditure next year to expand capacity, meet customer demand and fuel revenue growth.
The chipmaker this year budgeted between US$40 billion and US$44 billion for capital expenditure, mainly to expand its advanced process technology capacity, including for 3-nanometer, 5-nanometer, 7-nanometer and next-generation 2-nanometer technology.
Over the past three years, TSMC spent US$62 billion on capital expenditure, which helped drive revenue growth of 48 percent over the period, the chipmaker said.
Photo: Grace Hung, Taipei Times
This year, revenue is expected to increase 30 percent annually, TSMC chairman Mark Liu (劉德音) told the company’s annual general meeting in Hsinchu yesterday.
“TSMC is entering a structural and high-growth phase. During the year before last year, [revenue] grew 30 percent [annually]. The growth was 20 percent last year. This year, the growth will be 30 percent. Looking forward, we see this high growth will continue, so we have to expand capital spending,” Liu said.
To fund its massive investment, TSMC held back on plans to boost cash dividends after some shareholders requested that the chipmaker pay higher dividends, Liu said.
TSMC‘s board of directors has approved a plan to distribute a cash dividend of NT$2.7 per share for the first quarter of this year.
The company’s projection comes amid concerns that inflation, the war in Ukraine and COVID-19 lockdowns in China could hammer demand for gadgets.
TSMC executives acknowledged that smartphones and computers have been hit hard, but said that spending in other areas, such as electric vehicles (EVs), exceeded expectations.
They played down the effects of inflation, saying the increase in prices was gradually abating.
“The current inflation has no direct impact on the semiconductor industry, as the demand drop is mainly for consumer devices like smartphones and PCs, while EV demand is very strong and partially exceeds our supply capacity, so we are making inventory adjustments,” Liu said. “The utilization rate is full for the rest of the year.”
In response to a shareholder’s question about whether TSMC would build its next overseas fab in Italy or Germany, Liu said the company is still evaluating all possible locations in Europe.
No substantial conclusion has been made, he added.
“Satisfying customers’ demand is our main consideration when building an overseas fab. That is also why we decided to build a fab in the US and Japan. In Europe, we have fewer customers,” Liu said.
The chipmaker is on track to build a new fab in Japan’s Kumamoto Prefecture through a joint venture with Sony Semiconductor Solutions Corp and Denso Corp, Liu said.
The parties have recruited sufficient talent in Japan for the new fab, alleviating shareholders’ concerns about a shortage of semiconductor talent in Japan, Liu said.
The fab is expected to start making 28-nanometer chips at the end of 2024, TSMC said.
Manufacturing costs in the US are higher than expected, but are still manageable, the chipmaker said.
TSMC is not worried about being excluded from a chip manufacturing subsidy bill by the US, which could affect its profitability, Liu said, adding that its long-term gross margin target of 53 percent is achievable.
The chipmaker does not expect Japan-US cooperation in the production of 2-nanometer chips to pose a threat to TSMC’s competitiveness, Liu said.
TSMC has made good progress in developing its 2-nanometer technology in terms of yield rate, he added.
Additional reporting by Bloomberg
GlaxoSmithKline (GSK) in July made its consumer health products division a separate entity as it transforms into a world-leading biopharmaceutical company. By uniting science, technology and talent, the company is aiming to prevent and treat diseases with innovative vaccines, specialty pharmaceuticals and general medicines. GSK’s headquarters annually invests NT$192 billion (US$6.07 billion) in research and development, focusing on immune science and advanced technologies in human genetics. GSK’s drug and vaccine development focuses on infectious diseases, HIV, oncology and immunology. Investing in clinical trial research each year, GSK also brings drug development to Taiwan. It cooperates with 17 medical institutes and research
SLUMPING DEMAND: Inventory has climbed by up to 12 weeks as suppliers are under mounting pressure to offload excessive reserves, a TrendForce report said The price of DRAM chips is expected to fall at a steeper rate of 13 to 18 percent next quarter, as high inflation continues to weigh on demand for consumer electronics, causing chip inventories to soar, market researcher TrendForce Corp (集邦科技) said yesterday. The downtrend in DRAM prices could extend from a quarterly decline of 10 to 15 percent in the third quarter, the Taipei-based researcher said. “Demand for consumer electronics continued to stagnate during the third quarter, which used to be a high demand season,” TrendForce said in a statement. “During the quarter, memorychip consumption and shipments both showed quarterly
INEXPENSIVE POWER: Group chairman Gautam Adani said 70% of the investment would go into energy transition, with a focus on green hydrogen India’s Adani Group is to invest more than US$100 billion over the next decade, most of it in the energy transition business, chairman Gautam Adani said yesterday, as the ports-to-energy conglomerate accelerates an already aggressive expansion plan. After founding the group in 1988 as a commodities trading business, the 60-year-old has ventured into multiple sectors, mainly in the infrastructure space and in line with the priorities of the government of Indian Prime Minister Narendra Modi. “As a group, we will invest over US$100 billion of capital in the next decade,” Adani, the world’s second-richest person, told the Forbes Global CEO Conference in
Foxconn Technology Group (富士康科技集團) is to invest US$1.75 million in a joint venture with PT Indika Energy Tbk to explore commercial electric vehicle (EV) and electric battery business opportunities in Indonesia, the Taipei-based company said yesterday. With the investment, Foxconn would hold a 40 percent stake in the joint venture, PT Foxconn Indika Motor, while PT Indika would own 60 percent. The collaboration is an extension of a memorandum of understanding signed in January by Indika Energy, Foxconn, Gogoro Inc (睿能創意) and others aiming to build an electric vehicle supply chain in Southeast Asia’s biggest economy. Gogoro, in which Foxconn owns a 0.76
RSS